We are live on ! Find out more
IOVA icon

Iovance Biotherapeutics
IOVA

252 hedge funds and large institutions have $4.58B invested in Iovance Biotherapeutics in 2020 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 83 increasing their positions, 91 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $52.7M | Put options by funds: $26.5M

18% more capital invested

Capital invested by funds: $3.88B → $4.58B (+$704M)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

0.67% less ownership

Funds ownership: 96.25% → 95.58% (-0.67%)

9% less repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 91

10% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 51

2% less funds holding

Funds holding: 257 → 252 (-5)

Holders
252
Holders Change
-5
Holders Change %
-1.95%
% of All Funds
5.08%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.18%
New
46
Increased
83
Reduced
91
Closed
51
Calls
$52.7M
Puts
$26.5M
Net Calls
+$26.2M
Net Calls Change
-$19.2M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$112M
2
Franklin Resources
Franklin Resources
California
+$41.6M
3
NAMA
Nikko Asset Management Americas
New York
+$23.5M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$23.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$13.4M

Top Sellers

1
PA
Perceptive Advisors
New York
-$52.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$30M
3
ACA
Avoro Capital Advisors
New York
-$25.3M
4
EAM
Eagle Asset Management
Florida
-$19.8M
5
Goldman Sachs
Goldman Sachs
New York
-$18.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
126
Verition Fund Management
Connecticut
$1.17M +$724K +23,601 +196%
TAM
127
Tocqueville Asset Management
New York
$1.15M – – –
IP
128
Intellectus Partners
California
$1.14M +$154K +5,015 +17%
Baird Financial Group
129
Baird Financial Group
Wisconsin
$1.09M +$130K +4,233 +15%
CIP
130
Chartwell Investment Partners
Pennsylvania
$1.07M – – –
ASRS
131
Arizona State Retirement System
Arizona
$1.07M +$252K +8,218 +34%
FIA
132
FNY Investment Advisers
New York
$1.07M +$996K +32,500 New
FAM
133
Fred Alger Management
New York
$1.03M -$1.11M -36,295 -54%
Stifel Financial
134
Stifel Financial
Missouri
$1.03M +$32.2K +1,050 +3%
AQR Capital Management
135
AQR Capital Management
Connecticut
$987K -$2.43M -79,292 -72%
CSS
136
Cubist Systematic Strategies
Connecticut
$950K -$7.94M -259,052 -90%
AB
137
Amalgamated Bank
New York
$918K -$5.46K -178 -0.6%
CRC
138
Curi RMB Capital
Illinois
$900K -$106K -3,468 -11%
DekaBank Deutsche Girozentrale
139
DekaBank Deutsche Girozentrale
Germany
$894K +$852K +27,800 New
OC
140
Oppenheimer & Co
New York
$783K +$115K +3,744 +19%
ProShare Advisors
141
ProShare Advisors
Maryland
$777K +$19.1K +623 +3%
TIA
142
Traphagen Investment Advisors
New Jersey
$706K +$415K +13,537 New
Handelsbanken Fonder
143
Handelsbanken Fonder
Sweden
$675K – – –
PAM
144
Premier Asset Management
Illinois
$652K +$370K +12,081 +156%
VF
145
Virtu Financial
New York
$616K -$34.3K -1,120 -6%
Public Employees Retirement Association of Colorado
146
Public Employees Retirement Association of Colorado
Colorado
$616K – – –
State of Wisconsin Investment Board
147
State of Wisconsin Investment Board
Wisconsin
$608K +$21.2K +690 +4%
WG
148
Winton Group
United Kingdom
$605K +$563K +18,365 New
B
149
Bailard
California
$583K -$21.5K -700 -4%
AG
150
Aperio Group
California
$578K +$78.7K +2,567 +17%
4 5
6
7 8

IOVA Hedge Fund Activity: Q3 2020 in Review

252 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Iovance Biotherapeutics (IOVA) for Q3 2020, worth a combined $4.58B — up 18% from $3.88B a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of IOVA and 46 opened new positions — a net loss of 5 holders — while 91 trimmed existing stakes and 83 added.

The largest buyer was ARK Investment Management, adding an estimated $112M. The largest seller was Perceptive Advisors, cutting an estimated $52.8M.

  • 252 institutional investors held Iovance Biotherapeutics (IOVA) as of Q3 2020, down from 257 in Q2 2020.
  • Funds reported $4.58B of Iovance Biotherapeutics stock for Q3 2020, up 18% quarter-over-quarter.
  • 46 funds opened new Iovance Biotherapeutics positions in Q3 2020 and 51 closed out, a net change of -5 holders.
  • The largest Iovance Biotherapeutics buyer in Q3 2020 was ARK Investment Management, an estimated $112M added.
  • The largest Iovance Biotherapeutics seller in Q3 2020 was Perceptive Advisors, an estimated $52.8M sold.

Based on aggregated 13F filings for Q3 2020.